These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 6688376

  • 1. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

  • 2. Local application of interferon to malignant brain tumors.
    Nagai M, Arai T, Kohno S, Kohase M.
    Tex Rep Biol Med; 1983 Sep; 41():693-8. PubMed ID: 7052705
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O, Teramoto A, Yamamoto H, Ochiai C, Takakura K, Maruo K, Ueyama Y, Shimamura K.
    No To Shinkei; 1983 Sep; 35(9):905-11. PubMed ID: 6651989
    [Abstract] [Full Text] [Related]

  • 5. [Interferon therapy for brain tumor patients (author's transl)].
    Ueda S, Hirakawa K, Suzuki K, Nakagawa Y, Ibayashi N, Kishida T.
    No Shinkei Geka; 1982 Feb 10; 10(2):149-54. PubMed ID: 6174892
    [Abstract] [Full Text] [Related]

  • 6. [Current status of interferon therapy on malignant brain tumor].
    Nagai M, Arai T, Kohno S, Iizuka E.
    Gan No Rinsho; 1983 May 10; 29(6):608-15. PubMed ID: 6876429
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
    Shimura T, Nakazawa S, Takahashi H, Node Y, Tamai J, Kumazaki T.
    Gan To Kagaku Ryoho; 1994 Feb 10; 21(2):209-18. PubMed ID: 8311491
    [Abstract] [Full Text] [Related]

  • 8. Autologous natural killer cell therapy for human recurrent malignant glioma.
    Ishikawa E, Tsuboi K, Saijo K, Harada H, Takano S, Nose T, Ohno T.
    Anticancer Res; 2004 Feb 10; 24(3b):1861-71. PubMed ID: 15274367
    [Abstract] [Full Text] [Related]

  • 9. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr 10; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

  • 10. [Advances of BRM therapy of malignant brain tumors].
    Nagai M.
    Gan To Kagaku Ryoho; 1991 Feb 10; 18(2):188-94. PubMed ID: 1992912
    [Abstract] [Full Text] [Related]

  • 11. [Natural killer activity in brain tumor patients treated with interferon and steroid].
    Nakagawa Y, Ibayashi N, Ueda S, Hirakawa K, Amagai T, Imanishi J, Fukuma S.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2305-13. PubMed ID: 3831175
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
    Takakura K, Matsutani M, Koyama Y, Sing OK.
    No To Shinkei; 1972 May 20; 24(5):585-93. PubMed ID: 4340910
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience with alpha and beta interferon in childhood cancer].
    Ise T, Ohira M, Takayama J, Hanada M, Muchi H, Fukuma H, Beppu Y, Nomura K.
    Gan To Kagaku Ryoho; 1984 Sep 20; 11(9):1855-62. PubMed ID: 6591860
    [Abstract] [Full Text] [Related]

  • 15. [Local chemotherapy of cancer. Intrathecal administration].
    Nagai M.
    Gan To Kagaku Ryoho; 1989 Feb 20; 16(2):156-64. PubMed ID: 2465738
    [Abstract] [Full Text] [Related]

  • 16. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
    Fine HA, Wen PY, Robertson M, O'Neill A, Kowal J, Loeffler JS, Black PM.
    Clin Cancer Res; 1997 Mar 20; 3(3):381-7. PubMed ID: 9815695
    [Abstract] [Full Text] [Related]

  • 17. [Effect of interferon on malignant brain tumor].
    Wakabayashi T, Yoshida J, Kobayashi T, Kageyama N, Kanzaki M.
    Gan To Kagaku Ryoho; 1982 Aug 20; 9(8):1400-6. PubMed ID: 7184455
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K, Kanaya H, Fujiyama Y, Kim P.
    Acta Neurochir (Wien); 2002 Dec 20; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [Abstract] [Full Text] [Related]

  • 19. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
    Maluish AE, Ortaldo JR, Conlon JC, Sherwin SA, Leavitt R, Strong DM, Weirnik P, Oldham RK, Herberman RB.
    J Immunol; 1983 Jul 20; 131(1):503-7. PubMed ID: 6863923
    [Abstract] [Full Text] [Related]

  • 20. Effect of human leukocyte interferon on malignant brain tumors.
    Hirakawa K, Ueda S, Nakagawa Y, Suzuki K, Fukuma S, Kita M, Imanishi J, Kishida T.
    Cancer; 1983 Jun 01; 51(11):1976-81. PubMed ID: 6839290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.